Praxis Precision Medicines Total Liabilities

Praxis Precision Medicines (PRAX) currently reports a total liabilities of $50M as of March 2026. That compares with $40M in the prior-year period — up 27.1% year over year. Use the charts on this page to explore Praxis Precision Medicines's total liabilities history and peer comparisons.

Praxis Precision Medicines's total liabilities increased from $40M to $50M — a 27.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Praxis Precision Medicines reported $50M in total liabilities as of March 2026. That compares with $40M in the prior-year period — up 27.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $50M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Praxis Precision Medicines, and consider following PRAX for alerts when major investors trade the stock.

Praxis Precision Medicines is classified in the Healthcare sector. On total liabilities, it currently shows $50M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRAX with unrelated industries.